Metabolic Risk Factors of Sporadic Alzheimer's Disease: Implications in the Pathology, Pathogenesis and Treatment-Reference-Cited by-同舟云学术

Metabolic Risk Factors of Sporadic Alzheimer's Disease: Implications in the Pathology, Pathogenesis and Treatment

Published:2015 Issue:4 Volume:6 Page:282
ISSN:2152-5250
Container-title:Aging and disease
language:en
Short-container-title:Aging and disease

Author:

Chakrabarti Sasanka,Kumar Khemka Vineet,Banerjee Anindita,Chatterjee Gargi,Ganguly Anirban,Biswas Atanu

Publisher

Aging and Disease

Subject

Cell Biology,Neurology (clinical),Geriatrics and Gerontology,Pathology and Forensic Medicine

Link

http://www.aginganddisease.org/fileup/2152-5250/PDF/2152-5250-2015-4-282.pdf

Reference189 articles.

1. Reitz C, Brayne C, Mayeux R (2011). Epidemiology of Alzheimer disease, Nat Rev Neurol, 7:137-152.

2. Duthey B (2013). Background Paper 6.11. Alzheimer Disease and other Dementias. 6.11: 4-74.

3. van der Flier WM, Scheltens P (2005). Epidemiology and risk factors of dementia, J Neurol Neurosurg Psychiatry, 76:v2-7.

4. Bird TD(2012). Early-onset familial Alzheimer disease. In: Pagon RA, Adam MP, Ardinger HH, Bird TD, Dolan CR, Fong CT, Smith RJH, Stephens K, editors. Gene Reviews. Seattle: NCBI, 1-17.

5. Swerdlow RH (2007). Pathogenesis of Alzheimer's disease. Clin Interv Aging. 2:347-359.

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protein folding, cellular stress and cancer;Progress in Biophysics and Molecular Biology;2024-09

2. Application of engineered antibodies (scFvs and nanobodies) targeting pathological protein aggregates in Alzheimer’s disease;Expert Opinion on Investigational Drugs;2024-08-26

3. Toward the development of a sporadic model of Alzheimer's disease: comparing pathologies between humanized APP and the familial J20 mouse models;Frontiers in Aging Neuroscience;2024-07-08

4. Ellagic Acid Reverses Alterations in the Expression of AMPA Receptor and Its Scaffolding Proteins in the Cerebral Cortex and Memory Decline in STZ-sporadic Alzheimer’ s Disease Mouse Model;Psychopharmacology;2024-06-06

5. Alzheimer’s disease and its treatment–yesterday, today, and tomorrow;Frontiers in Pharmacology;2024-05-24